$5,751.07 speaking Payment -- AbbVie Inc to Dr. Robert Johnson

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

AbbVie Inc made a $5.8K speaking payment to Robert Johnson, a Dermatology specialist in City, WI. The payment was associated with Jardiance. Dr. Robert Johnson received $5,751.07 from AbbVie Inc. for speaking engagements related to Jardiance. The payment was for serving as faculty or a speaker, indicating an educational or promotional role. This payment falls within the typical range for speaking fees in the pharmaceutical industry.

Patient Guidance: What This Payment Means for You

If your doctor speaks about medications, it's often to educate others on their use and benefits. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Speaking fees for faculty or speaker roles are common in the pharmaceutical industry, with amounts varying based on the engagement's scope and duration.

Regulatory Context: Sunshine Act Requirements

Payments to physicians for speaking engagements are subject to disclosure under the Open Payments program to ensure transparency in industry relationships.

Related Topics

This payment is related to the following healthcare transparency topics:

• speaking-fees
• speaker-honoraria
• pharmaceutical-payments
• abbvie-inc
• jardiance
• dermatology

Understanding speaking Payments

Speaking and education payments compensate physicians for presenting at conferences, continuing medical education (CME) events, and promotional speaking engagements. These payments often cover honoraria, preparation time, and travel expenses. Speaking fees are among the highest-value payment categories and have attracted significant attention from researchers studying potential conflicts of interest.

Frequently Asked Questions About This Payment

What was this $5.8K payment for?

This was a speaking payment of $5.8K from AbbVie Inc to Robert Johnson, categorized as "Compensation for serving as faculty or as a speaker". It was associated with Jardiance. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Robert Johnson accept pharmaceutical money?

Yes, Robert Johnson received this $5.8K payment from AbbVie Inc. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Robert Johnson's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this speaking payment?

A speaking payment of $5.8K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Dermatology?

To compare this payment against Dermatology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Dermatology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Robert Johnson's relationship with AbbVie Inc?

The payment was specifically for 'Compensation for serving as faculty or as a speaker'. This $5.8K speaking payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Dermatology?

AbbVie Inc. is the pharmaceutical company making the payment.

What should patients do after learning about this payment?

If your doctor speaks about medications, it's often to educate others on their use and benefits.

What else should I know about this speaking payment?

The drug/device associated with the payment is Jardiance.

Related Reports

• View Dr. Robert Johnson's full payment report
• AbbVie Inc full spending report
• Browse all Dermatology payments
• Browse all payments in Wisconsin
• Search for other payments